A team of more than 50 scientists have changed the face of skincare with a revolutionary 'world-first' innovation using the advance science of Artificial Intelligence, computer algorithms, machine learning, robotics and computer modelling. Through global collaboration and expertise from the University of Liverpool, Nottingham, and Manchester, Nottingham's Boots today (Monday, April 10) unveils No7 Future Renew - a collection of four skincare products proven to reverse the appearance of multiple signs of skin damage. The products are expected to fly off the shelves when released.
The range will be sold exclusively at Boots stores and online from April 12 and comprises a Serum, Eye Serum, Night Cream and Day Cream with SPF40. At the heart of the collection is the No7 Future Renew Damage Reversal Serum, clinically proven to reverse the appearance of multiple signs of skin damage across a range of skin types and tones, including fine lines, wrinkles, lack of luminosity, dryness, uneven skin tone and loss of firmness. In No7’s most diverse testing programme, 97% of women in the clinical study reported improvements in the appearance of multiple visible signs of skin damage. More than 4,200 women took part in 37 studies, including two clinical trials and 23 user trials.
The technical lead on the team lives in Beeston, and is 34-year-old Dr Eleanor Bradley, Science Credentialing Manager at No7 Beauty Company, who has spoken to Nottinghamshire Live exclusively about the game-changing new skincare product using a new "super peptide" (Peptides are amino acids that make up certain proteins needed by the skin).
.jpg?w=600)
